Consultar sobre " Oseltamivir Mono Allyl Impurity "
Oseltamivir Mono Allyl Impurity
| N° de SZ CAT: | SZ-O003100 |
| Número CAS | NA |
| Mol.F. | C20H34N2O3 |
| Peso Molecular |
350.5 |
| Status de Fatura |
Synthesis on demand |
Nome Químico: Ethyl (3R,5S)-4-acetamido-5-(allylamino)-3-(2-ethylbutyl)cyclohex-1-ene-1-carboxylate
Temperatura de envío:
Código HSN: 38229010
País de origen: India
Sorrisos: CCC(CC)C[C@H]1C(NC(C)=O)[C@@H](NCC=C)CC(C(OCC)=O)=C1
Oseltamivir Mono Allyl Impurity is chemically Ethyl (3R,5S)-4-acetamido-5-(allylamino)-3-(2-ethylbutyl)cyclohex-1-ene-1-carboxylate. Oseltamivir Mono Allyl Impurity is supplied with detailed characterization data compliant with regulatory guideline. Oseltamivir Mono Allyl Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oseltamivir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Buscar por palabras clave
buy high quality Oseltamivir Mono Allyl Impurity
Comprar Oseltamivir Mono Allyl Impurity
Oseltamivir Mono Allyl Impurity fornecedores
Oseltamivir Mono Allyl Impurity fabricantes
Oseltamivir Mono Allyl Impurity preço
Oseltamivir Mono Allyl Impurity Exportador
Encomendar Oseltamivir Mono Allyl Impurity
Consultar Oseltamivir Mono Allyl Impurity
Oseltamivir Mono Allyl Impurity custo
Oseltamivir Mono Allyl Impurity Fornecedor
Oseltamivir Mono Allyl Impurity Distribuidor
Produtos Relacionados
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.


